Interested in contributing to the emerging area of Drug Discovery on targeting protein N-terminal methylation and/or acetylation? We are currently hiring for a new member at Huang Lab and we have a position immediately available. The position requires a PhD in Cancer biology, Biochemistry, Medicinal Chemistry, or Chemical biology. For more information, please contact Dr. Rong Huang at huang-r at purdue dot edu. Please make the subject of your message: ‘Post Doc Position’.
WHO WE ARE
Huang Lab at Purdue University applies a multidisciplinary approach to elucidate the mechanisms and functions of epigenetic modifications including methylation and acetylation. The research focuses on developing novel therapeutic agents for cancer, metabolic, infectious, and neurodegenerative diseases; rational design and synthesizing selective and potent inhibitors for methyltransferases and acetyltransferases; developing HTS assay and efficiently creating compound libraries to screen hits for structural optimization.
Every day is a new opportunity to maximize your potential. Together, we make a difference. We believe that diversity drives creativity and innovation. We enjoy sharing and helping each other and are committed to creating a diverse, inclusive, and supportive training space for all lab members with diverse backgrounds. We believe that with teamwork, perseverance, and hard work, anything is possible.